| Application no. and date | 93920822.9 (espacenet) (Federated) (European Patent Register), 19930924 | | Patent/reg. no. and date | DK/EP 0663916, 19981125 | | Publication date | 19950726 | | Priority no. and date | GB 9221220, 19921009 | | EP pub. no. and date |
EP 0663916 19950726 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
CH-4056 Basel, CH | | Applicant ref. no. | 59260 | | Inventor | COTTENS, Sylvain, In den Reben 12
CH-4108 Witterswil, CH,
SEDRANI, Richard, Herrengrabenweg 15
CH-4054 Basle, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K, DK | | Opponent | | | IPC Class | A61K 31/435, C07F 7/18, C07D 498/18 | | Title | O-alkyleret rapamycinderivat og dets anvendelse, især som immunosuppressivt middel | | Int. application no. | PCT/EP93/02604 | | Int. publication no. | WO/9409010 | | Related patent (certificate) | CA 2004 00020 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
